In order to determine whether these data are relevant clinically, secondary analysis of clinical trials utilizing EGFR-targeting agents together with chemotherapeutics that cause alopecia was undertaken, revealing evidence of a role for EGFR in alopecia in cancer patients. The gene discussed is EGFR; the disease is cancer.